Global Neurology Devices Market Size By Type (Neuro-Stimulation Devices, Interventional Devices), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Neurology Devices Market Report Description

The Global Neurology Devices Market was valued at USD 11.3 billion in 2023 and is projected to reach USD 21.7 billion by 2031, expanding at a CAGR of 8.4% during the forecast period (2023–2031). This growth is driven by the rising prevalence of neurological disorders, technological advancements in neuromodulation and neuroimaging, and increasing awareness about early diagnosis. An aging population and rising healthcare expenditure are further accelerating the demand for innovative neurology devices used in diagnosis, monitoring, and treatment of conditions such as Alzheimer’s, Parkinson’s, epilepsy, and multiple sclerosis.

Drivers

1. Rising Incidence of Neurological Disorders:

The growing burden of neurological diseases globally, especially among the aging population, is increasing the need for advanced diagnostic and therapeutic devices. Conditions like Alzheimer’s and stroke are becoming more prevalent, driving market demand.

2. Technological Advancements in Neuromodulation and Imaging:

Ongoing innovations in brain-computer interfaces, deep brain stimulators, and minimally invasive procedures are enhancing patient outcomes. These advancements are enabling real-time monitoring and precise targeting of affected areas, improving treatment efficacy.

3. Growing Demand for Non-Invasive and Portable Devices:

Healthcare systems are increasingly adopting portable, wearable, and non-invasive neurology devices to facilitate point-of-care diagnostics and home monitoring, particularly in resource-limited settings.

Restraints

1. High Cost of Neurology Devices and Procedures:

The substantial costs associated with advanced neurology devices, particularly neurostimulation and robotic-assisted technologies, can deter adoption in low-income and developing countries.

2. Stringent Regulatory Approval Processes:

Neurology devices often require complex clinical trials and regulatory scrutiny to ensure safety and efficacy, which can delay product launches and limit market growth.

Opportunity

1. Expansion into Emerging Markets:

Rising healthcare investment, improving diagnostic infrastructure, and government initiatives in regions like Asia-Pacific and Latin America present immense growth opportunities for neurology device manufacturers.

2. Integration of AI and IoT in Neurodiagnostics:

The convergence of artificial intelligence and connected devices is transforming neurology diagnostics and patient monitoring. This digital integration facilitates early disease detection and remote care, enhancing treatment outcomes.

Market by System Type Insights

Based on system type, Neurostimulation Devices held the largest market share in 2023, driven by their effectiveness in treating chronic pain, epilepsy, and movement disorders. However, the Neurodiagnostic Devices segment is anticipated to grow at the fastest rate, fueled by rising investments in non-invasive brain imaging and early detection systems.

Market by End-use Insights

The Hospitals & Surgical Centers segment dominated the market in 2023, owing to the availability of specialized neurologists, advanced infrastructure, and comprehensive patient care services. Meanwhile, the Homecare Settings segment is emerging rapidly, supported by the rise in remote monitoring devices and patient-centric care models.

Market by Regional Insights

North America accounted for the largest share of the global neurology devices market in 2023, attributed to a high prevalence of neurological diseases, favorable reimbursement policies, and robust R&D investment. Asia-Pacific is projected to register the highest growth rate through 2031, driven by aging demographics, increasing healthcare access, and regional expansions by key market players.

Competitive Scenario

Major players in the Global Neurology Devices Market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nihon Kohden Corporation, Stryker Corporation, GE Healthcare, Philips Healthcare, Nevro Corp, and Natus Medical Incorporated. These companies are actively engaged in product innovation, strategic acquisitions, and expanding their geographic footprint.

In 2023, Medtronic launched an AI-enabled deep brain stimulation system for personalized treatment of Parkinson’s disease.

Abbott expanded its neuromodulation portfolio by acquiring a start-up focused on closed-loop spinal cord stimulation.

GE Healthcare introduced a portable EEG system integrated with cloud analytics for remote patient monitoring in 2024.

Scope of Work – Global Neurology Devices Market

Report Metric Details

Market Size (2023) USD 11.3 billion

Projected Market Size (2031) USD 21.7 billion

CAGR (2023–2031) 8.4%

Market Segments System Type (Neurostimulation, Neurodiagnostics), End-use (Hospitals, Home